Roundtable discussion: regulatory, scientific and ethical issues relating to genetic testing : roundtable discussion before the Special Committee on Aging, United States Senate, One Hundred Tenth Congress, second session, Washington, DC, June 12, 2008, Volume 4
U.S. G.P.O., 2009 - Law - 53 pages
What people are saying - Write a review
We haven't found any reviews in the usual places.
Opening Statement of Senator Gordon H Smith
Statement of Kathy Hudson Ph D Director Genetics and Public Policy
23andMe ACLA actually agencies Avey breast cancer Centers for Medicare CLIA CLIA-certified clinical validity CLlA colon cancer cystic fibrosis Daynard developed diagnostic direct-to-consumer directly to consumers Director Drug Administration Elaine Factor V Leiden Federal Trade Commission Feero Food and Drug Gene variation genetic counselors genetic information Genetic test identifies going Greg Gutman Hamilton hearing heart disease Hinkle HIPPA HlNKle Hudson Human Genome Project important interpret issue Judy Kathy look Lyon means Medicaid Services Medicare molecular testing move forward patients performed personalized medicine physicians professional proficiency testing question regulation regulatory require risk roundtable SACGHS report sample scientific Senator Smith sort Steve studies sumers talking tests for rare there's things tion type 2 diabetes type of testing unsubstantiated claims validate tests Warfarin what's Yost